Home
Centro de productos
Enfermedad infecciosa
Embarazo & Fertilidad
Gastroenteritis
Prueba STI
Drogas de abuso
Marcadores cardíacos
COVID-19
Salud de las mascotas
Sobre nosotros
News Center
Contacte con nosotros
Elección del idioma
English
Español
ภาษาไทย
Synthgene News丨Jiangsu Provincial Food and Drug Administration Director Tian Feng investigates Synthgene
04
2022
/
Synthgene Medical| Home self-test OTC hot hits are coming!
On April 1, 2022, SARS-CoV-2 (2019-nCoV) antigen detection kit (colloidal gold) developed by Nanjing Synthgene Technology Co., Ltd. (“ Synthgene”), a wholly-owned subsidiary of Jiangsu Synthgene Biotechnology Co., Ltd. Law) obtained the "Medical Device Registration Certificate" issued by the National Medical Products Administration (NMPA).
Blockbuster丨SARS-CoV-2's antigen detection reagent was successfully approved in China!
01
Industry News丨Experts "high-profile delivery" SARS-CoV-2 home self-test, Synthgene OTC products are complete!
17
03
CACLP丨 Synthgene invites you to "prosper" to enjoy the diagnosis ceremony together!
From March 27th to 29th, 2022, Synthgene will participate in the 19th China International Medical and Blood Transfusion Instrument and Reagent Expo (CACLP) held in Nanchang International Expo Center.
